Table 1 Baseline clinical characteristics in patients with AF who undergoing complex or non-complex PCI
Overall (n = 1132) | Non-complex PCI (n = 812) | Complex PCI (n = 320) | p value | |
|---|---|---|---|---|
Age | 67 ±9 | 67 ±9 | 67 ±8 | 0.65 |
BMI | 25.83 ±3.35 | 25.81 ±3.40 | 25.86 ±3.22 | 0.81 |
SBP | 132 ±19 | 131 ±19 | 133 ±18 | 0.21 |
DBP | 78 ± 11 | 78 ± 12 | 77 ± 11 | 0.69 |
HR | 70 [64, 80] | 70 [63, 80] | 70 [64, 80] | 0.69 |
Sex(male) | 850 (75.1%) | 597 (73.5%) | 253 (79.1%) | 0.06 |
Index ACS | 659 (58.2%) | 484 (59.6%) | 175 (54.7%) | 0.15 |
AF type | 0.55 | |||
Paroxysmal AF | 26 (2.3%) | 23 (2.8%) | 3 (0.9%) | |
Non-paroxysmal AF | 1106 (97.7%) | 789 (92.7%) | 327 (99.1%) | |
Medical history | ||||
HF | 173 (15.3%) | 114 (14.0%) | 59 (18.4%) | 0.08 |
Hypertension | 886 (78.3%) | 641 (78.9%) | 245 (76.6%) | 0.43 |
Hyperlipidemia | 880 (77.7%) | 634 (78.1%) | 246 (76.9%) | 0.72 |
DM | 479 (42.3%) | 338 (41.6%) | 141 (44.1%) | 0.50 |
CKD | 88 (7.8%) | 65 (8.0%) | 23 (7.2%) | 0.73 |
Hyperthyroidism | 76 (6.7%) | 61 (7.5%) | 15 (4.7%) | 0.12 |
Stroke/TIA | 262 (23.1%) | 188 (23.2%) | 74 (23.1%) | 1.00 |
Major bleeding | 42 (3.7%) | 29 (3.6%) | 13 (4.1%) | 0.83 |
Laboratory test | ||||
Serum K | 4.19 ± 0.42 | 4.18 ± 0.42 | 4.21 ± 0.41 | 0.26 |
Hemoglobin | 145.11 ±17.17 | 144.96 ±17.71 | 145.51 ±15.71 | 0.61 |
PLT | 210.00 [174.25, 247.00] | 210.00 [174.25, 248.00] | 209.00 [1774.25, 243.50] | 0.56 |
LDL | 2.21 [1.78, 2.82] | 2.22 [1.79, 2.83] | 2.17 [1.74, 2.80] | 0.46 |
HAb1c | 6.6 ± 1.2 | 6.6 ± 1.2 | 6.7 ± 1.2 | 0.20 |
Peak cTnI | 3.00 [0.50, 18.83] | 2.70 [0.40, 14.10] | 4.25 [0.90, 24.92] | 0.01 |
Peak NT-proBNP | 724.40 [248.00, 1910.23] | 724.40 [246.60, 1838.92] | 765.20 [250.88, 2026.25] | 0.44 |
Cr Clearance | 78.96 [66.82, 91.81] | 79.48 [66.76, 92.22] | 78.31 [67.48, 90.77] | 0.56 |
LV | 50.06 ± 5.99 | 49.86 ± 5.79 | 50.59 ± 6.44 | 0.06 |
LA | 41.42 ± 6.44 | 41.33 ± 6.45 | 41.66 ± 6.41 | 0.43 |
LVEF | 58.10 ± 8.65 | 58.27 ± 8.38 | 57.66 ± 9.31 | 0.28 |
CHA2DS2-VASc score | 3 [2,4] | 3 [2,5] | 3 [2,4] | 0.81 |
HAS-BLED score | 2 [2,3] | 2 [2,3] | 2 [2,3] | 0.29 |
Total stent length | 42 ± 29 | 29 ± 13 | 76 ± 31 | < 0.001 |
Number of target vessels | 1 [1,2] | 1 [1,1] | 2 [1,2] | < 0.001 |
Number of lesions | 1 [1,2] | 1 [1,1] | 3 [2,3] | < 0.001 |
Number of implanted stents | 1 [1,2] | 1 [1,2] | 3 [2,3] | < 0.001 |